The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 375.00
Bid: 360.00
Ask: 374.00
Change: 11.00 (3.02%)
Spread: 14.00 (3.889%)
Open: 375.00
High: 375.00
Low: 375.00
Prev. Close: 364.00
WIL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

25 Feb 2014 07:00

RNS Number : 8213A
Wilmington Group Plc
25 February 2014
 



 

 

 

25 February 2014

WILMINGTON GROUP PLC

("Wilmington", "the Group" or "the Company")

Financial Results for the six months ended 31 December 2013

 

Wilmington Group plc, the provider of Information, Compliance and Education to professional markets today announces its interim results for the six months ended 31 December 2013.

 

Financial highlights

 

- Adjusted EBITA1 increased 15% to £8.2m (2012: £7.1m)

- Adjusted EBITA margin3 improved to 19.0% (2012: 17.4%)

- Adjusted Profit before Tax2 was up 18% to £7.1m (2012: £6.0m)

- Adjusted Earnings per Share4 were up 14% at 6.2p (2012: 5.5p)

- Group revenues for the period increased 5% to £43.1m (2012: £40.9m)

- Profit before tax at £3.7m (2012: £5.1m)

- Deferred revenue increased by 23% to £19.2m (2012: £15.6m)

- Resumption of progressive dividend policy; interim dividend increased from 3.5p to 3.6p

 

Operational highlights

 

- Acquisition of Compliance Week strengthens Wilmington's presence in the global governance, risk and compliance ("GRC") market and establishes a significant operational base in North America

- Growing international revenues; now 35% of consolidated revenue (2012: 29%)

- Subscriptions and repeatable revenue at 77% (2012:77%)

- Disposal of surplus freehold property for £700,000 in cash

- Strong momentum in Banking & Compliance and Pensions & Insurance

- Some challenging conditions in Healthcare and Legal markets

 

Current Trading

 

- Trading in line with management expectations, outlook for 2014 remains unchanged

 

Board Change

 

- As separately announced today, Charles Brady has informed the Board of his intention to retire as Group Chief Executive. Until the right successor is in place, Charles will remain as CEO and will work with the Board to ensure a smooth handover takes place.

 

Mark Asplin, Chairman, commented:

 

"Wilmington has had a good start to 2014. Recent acquisitions have been integrated and are contributing to Group performance. Our bigger businesses Banking & Compliance and Pensions & Insurance are performing well with each enjoying strong organic growth. As expected, Legal had a difficult end to the Legal CPD year and continues to face challenging market conditions. There have also been strong competitive pressures in our Healthcare division but our prognosis for the medium term is encouraging with new products and potentially new markets opening up for us.

 

Given our solid performance overall I am pleased to report that we have decided to reinstate our progressive dividend policy. In addition, cash flow is strong enabling us to invest in important internal systems which will provide the foundation for future growth, re-engineer the way we interact with our customers and transform the way we run our businesses.

 

The overall trading environment has not changed significantly since the full year 2013 results announcement. Wilmington is a well-balanced business which is increasingly international and, as we move into the second half, our financial performance is on track to support our current expectations for the full year."

 

Notes

1 Adjusted EBITA - see note 5 to the interim results

2 Adjusted Profit before Tax - see note 5 to the interim results

3 Adjusted EBITA margin - Adjusted EBITA divided by Revenue

4 Adjusted Earnings per Share - see note 11 to the interim results

5 Adjusted EBITDA - see note 5 to the interim results

Interim Financial Results

 

I am pleased to present my report on Wilmington's results for the six months ended 31 December 2013.

 

During the period, Wilmington has performed well and produced another solid performance with Adjusted EBITA1 up 15% to £8.2m from £7.1m in 2012. Adjusted Profit before Tax2 was up 18% to £7.1m (2012: £6.0m). Adjusted EBITA margins5 also increased to 19.0% up from 17.4% in the equivalent period in 2012.

 

Revenues were up 5% to £43.1m (2012: £40.9m), reflecting first time contributions from our three recent acquisitions, which were offset inter alia by some continued rationalisation and disposal of underperforming businesses.

 

Our biggest businesses continue to perform well in particular Pensions & Insurance and Banking & Compliance, and these are the areas where we are investing heavily for the Group's future growth. However, we are witnessing more challenging conditions in our Healthcare and Legal markets.

 

On 15 August 2013 we acquired Compliance Week, the leading provider of governance, risk and compliance ("GRC") information and events for public companies and large enterprises primarily in the US. Compliance Week, contributed £1.2m to revenue and £0.2m to profits in the six months ended 31 December 2013.

 

Underlying adjusted EBITA growth was 3% and underlying revenues were marginally down, 1% lower than the same period in 2012.

 

Business Strategy

 

Wilmington's strategy is to increase shareholder value by delivering sustainable and growing profits from servicing the information, compliance and education requirements of professional businesses globally.

 

Our investment strategy is focused on developing existing businesses and acquiring new ones, with high repeat revenues and strong, cash generative income streams both in the UK and overseas. The result of implementing this strategy is a business with an increasing proportion of revenues derived from subscriptions to products which disseminate content-rich, high-value information digitally. Tighter regulatory control and more complex legislation in our key markets will continue to drive the demand for our products and services, both in the UK and overseas.

 

Operational Review

 

Pensions & Insurance (19% of Group revenue and 36% of Group contribution)

This division, which includes Axco, Pendragon, Inese and ICP, provides in-depth regulatory and compliance information, market intelligence, events, training, analysis and workflow tools for the international insurance market and the UK pensions industry.

 

2013

2012

Movement

£'000

£'000

£'000

%

Revenue

8284

6534

1750

27

Contribution

3506

2886

620

21

Margin %

42

44

 

Divisional revenue grew 27% (£1.8m) helped by the addition of Inese, a provider of Spanish language subscription based publications, events and online services (acquired March 2013), which recorded revenue of £1.2m in the period. Underlying revenue growth was 7% for the division. Axco, which has continued to benefit from significant investment since joining the Group, also reported 7% revenue growth. Axco sales were helped by increasing demand from emerging markets.

 

Pendragon, the leading electronic regulatory information service for the UK Pensions Industry, maintained its market leading position and recorded steady revenue growth of 4%. ICP, the leading provider of credit insurance reports for developing markets, has seen a continued increase in demand for its reports, particularly in the Middle East, and delivered revenue growth of 17%.

 

On top of the continued investment in new products and associated infrastructure, divisional contribution grew by 21% to £3.5m (2012: £2.9m), reflecting the operational leverage within the business and a contribution of £0.2m from Inese. Underlying contribution growth was 11%, reflecting a growth in underlying margins from 44% to 46% excluding Inese.

 

Banking & Compliance (25% of Group revenue and 28% of Group contribution)

 

The Banking & Compliance division provides corporate finance and capital markets training and accredited programmes in GRC, anti-money laundering, financial crime and trust management. This division primarily serves major banks, the international financial services industry and multi -national companies.

 

2013

2012

Movement

£'000

£'000

£'000

%

Revenue

10728

8749

1979

23

Contribution

2692

2071

621

30

Margin %

25

24

 

The division continued its strong revenue growth with an increase of 23% (£2.0m) compared to the same period in 2012. Adjusting for currency movements and the acquisition of Compliance Week the underlying revenue growth was 9%.

 

ICT (compliance training) has continued to secure major in-house training assignments and has a strong pipeline of projects into 2014. Growth drivers for this division include the provision of compliance and anti-money laundering programmes to international banks and major multinational companies. We continue to see opportunities in emerging markets with recent initiatives in Malaysia and Poland.

 

AMT, which delivers most of its revenue and contribution during the summer months, has reported revenue growth of 7%, with a particularly strong performance from its graduate programmes in New York.

 

Our recent acquisition, Compliance Week, has had a good start to the year and the integration has gone well. We have seen promising growth in subscriptions since our restructuring of the marketing and sales teams. Initial forward bookings for the flagship "Compliance Week Annual Conference" look very encouraging. Compliance Week contributed £1.2m to revenue and £0.2m to profits.

 

Contribution for the division was 30% ahead of the same period last year at £2.7m (2012: £2.1m) on top of continued investment in new programmes, materials and support systems which will help drive future growth. Underlying contribution growth was 20%.

 

Healthcare (16% of Group revenue and 16% of Group contribution)

 

This division includes Agence de Presse Médicale, our French language medical news agency, NHiS, our pharmaceutical business intelligence and data analysis business and Binley's, our UK healthcare information business.

 

2013

2012

Movement

£'000

£'000

£'000

%

Revenue

6770

6009

761

13

Contribution

1551

1294

257

20

Margin %

23

22

 

Divisional revenue was up 13% (£0.8m) but, adjusting for currency movements and the acquisition of NHiS which recorded revenue of £1.1m and a contribution of £0.3m, the underlying revenue was down 7%. This underlying variance was within our Binley's business and related predominantly to a fall-off in lower margin mailing services and marketing list sales as well as competitive pressure on our subscription pharmaceutical CRM business. APM had another good trading period with revenue up 4%.

 

NHiS, a provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK, which was acquired in February 2013, had a strong finish to the period, and this is reflected in good deferred income balances at 31 December 2013. We have been investing in the next generation of data interrogation products as well as exploring some exciting international opportunities where the NHiS technology and processes are very relevant.

 

Contribution for the Healthcare division was up by 20% to £1.6m (2012: £1.3m). Adjusting for currency movements and the acquisition of NHiS underlying contribution was down 10%.

 

Legal (19% of Group revenue and 6% of Group contribution)

 

The Legal division provides a range of training, professional support services and information including Legal Continuing Professional Development (CPD), expert witness training, databases and magazines.

 

2013

2012

Movement

£'000

£'000

£'000

%

Revenue

8398

9510

-1112

-12

Contribution

577

657

-80

-12

Margin %

7

7

 

During the half year, revenue in this division reduced by 12% (£1.1m) with an underlying decline of 9%. This reduction reflects adverse trading conditions experienced during our peak period for public courses and a necessary resultant reduction in our prices. We have responded by decreasing our associated cost base by further rationalisation.

 

There were, however, positive improvements in our other legal markets in particular our Bond Solon expert witness familiarisation business which saw a 5% increase in revenues.

 

Despite the reduction of £1.1m in revenue the division's contribution reduced by only £0.1m to £0.6m (2012: £0.7m) mitigated by good cost control.

 

Business Intelligence (10% of Group revenue and 8% of Group contribution)

 

This division includes our Data Suppression and Fraud Prevention services as well as our Charities, Fund Management and Film & TV information services.

 

The division is undergoing the most significant transformation of all our businesses, as it continues to exit businesses dependent upon third party IPR and transitions from print-based information to digital services, subscription information products and workflow tools. Digital services now represent 69% of divisional revenues (2012: 68%).

 

2013

2012

Movement

£'000

£'000

£'000

%

Revenue

4268

5271

-1003

-19

Contribution

767

998

-231

-23

Margin %

18

19

 

Overall divisional revenue was down 19% (£1.0m) compared to the same period in the prior year, of which £0.9m was from exiting third party business, including a low margin email list brokerage service operated by Millennium. We saw traditional print related revenues drop £0.1m in the period. Underlying revenue decline adjusting for the brokerage business was 8%.

 

Contribution dropped by 23% to £0.8m (2012: £1.0m), reflecting the relatively fixed overhead base of the business with revenue reduction only partially offset by cost savings.

Accountancy (11% of Group revenue and 7% of Group contribution)

 

The Accountancy division is the leading provider of training, technical support and marketing services to accountancy firms in the UK.

 

2013

2012

Movement

£'000

£'000

£'000

%

Revenue

4699

4851

-152

-3

Contribution

680

727

-47

-6

Margin %

14

15

 

The first half of the year saw a slight reduction in face to face training demand caused by a lack of regulatory changes. These were partially offset by growth in our technical and marketing support business which represents about one third of our divisions business. Overall, divisional revenues declined by £0.2m (3%) and due to the relatively fixed overhead base, divisional contribution declined by £0.05m (6%) compared to the same period in the prior year.

 

Group Overheads

 

Group overheads, which include Board and head office salaries and associated costs, as well as unallocated central overheads, were flat at £1.5m.

 

Property Disposal

 

As indicated in the 2013 financial report we disposed of our surplus freehold property for £700,000 in October 2013. The profit on disposal net of associated costs was £32,000.

 

Financial Performance

 

Revenue for the six months to 31 December 2013 was up 5% (£2.2m) at £43.1m (2012: £40.9m). On a like-for-like basis (excluding the impact of acquisitions, foreign exchange and disposals) revenue was marginally down by 1% (£0.5m). Adjusted EBITA1 was up 15% at £8.2m (2012: £7.1m).

 

Adjusted Profit before Tax2 increased by 18% to £7.1m (2012: £6.0m). This reflects an increase in revenue in businesses operating with higher adjusted EBITA margins together with a flat interest cost of £1.1m (2012: £1.1m).

 

Profit before tax decreased to £3.7m from £5.1m, reflecting inter alia reduced exceptional costs this year and the net profit of £3.3m from the disposal of Paulton House in 2012.

 

Adjusted Earnings per Share4 increased by 14% to 6.22p (2012: 5.47p). Basic earnings per share decreased to 3.07p from 5.67p and diluted earnings per share decreased to 2.98p from 5.49p.

 

Balance Sheet

 

Net assets were maintained at £51.7m compared to 30 June 2013.

 

Goodwill and Intangible fixed assets increased by £4.2m due principally to the acquisition of Compliance Week offset by normal amortisation. Property, plant and equipment decreased by £0.2m to £5.7m, reflecting normal depreciation.

 

Trade receivables were up £1.0m, however adjusting for Compliance Week underlying trade receivables were down £0.1m compared to 30 June 2013, reflecting inter alia good credit control.

 

Trade and other payables were down £1.5m compared to 30 June 2013. Within this category, subscriptions and deferred income were up £0.7m compared to 30 June 2013 and up £3.6m (23%) compared to 31 December 2012. Of this increase of £3.6m, £2.7m relates to acquisitions made since 31 December 2012; an underlying increase of 6%.

 

 

Operating cash flows increased by £1.0m to £6.2m (2012: £5.2m). Overall, debt was up to £40.3m representing a net debt to EBITDA on a rolling 12 month basis of 2 times. This increase was due largely to our acquisition of Compliance Week for £7.3m ($11.2m). Cash flow conversion, which is seasonally low in the first six months, was 71% compared to 72% in the same period in 2012.

 

Capital Investment

 

The Group is increasingly evolving its online capabilities, products and services as well as its international footprint necessitating investment in global, future proof systems. Over the next two years in addition to ongoing product and systems development, the Group will be investing in new CRM, process management and CMS infrastructure including Salesforce.com. These exciting investments will provide the foundation for future growth, re-engineer the way we interact with our customers and transform the way we run our businesses.

 

Dividend

 

The Board is pleased to announce that given the improved financial performance of the business it will resume its progressive dividend policy and the interim dividend will increase from 3.5p per share to 3.6p per share, an increase of 3%. It is the Board's intention to grow the dividend each year whilst ensuring a suitable dividend cover is maintained. The interim dividend of 3.6p per share (2012: interim 3.5p) will be paid on 10 April 2014 to shareholders on the share register as at 14 March 2014.

 

Outlook

 

We have had a solid start to 2014 and the financial performance is on track to support our expectations for the full year. The overall trading environment has not changed significantly since the full year 2013 results announcement. Our bigger businesses Banking & Compliance and Pensions & Insurance are performing well with each enjoying strong organic growth. As expected, Legal had a difficult end to the Legal CPD year and continues to face challenging market conditions. There have also been strong competitive pressures in our Healthcare division but our prognosis for the medium term is encouraging with new products and potentially new markets opening up for us. As we move into the second half, cash flow is strong and will provide resources for further investment, a growing dividend and, in the absence of acquisitions, a reduction in our debt.

 

 

Mark Asplin

Chairman

 

 

 

1 Adjusted EBITA - see note 5 to the interim financial results

2 Adjusted Profit before Tax - see note 5 to the interim financial results

3 Group Contribution - see note 6 to the interim financial results

4 Adjusted Earnings per Share - see note 11 to the interim financial results

5 Adjusted EBITA margin - Adjusted EBITA divided by Revenue

 

 

 

 

 

Consolidated Income Statement

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30

June 2013

 

(unaudited)

(unaudited)

(audited)

Note

£'000

£'000

£'000

Revenue

6

43,147

40,924

85,048

Cost of sales

(12,302)

(12,557)

(26,064)

Gross profit

30,845

28,367

58,984

Operating expenses

 

(26,061)

 

(22,117)

 

(51,612)

Operating profit

5

4,784

6,250

7,372

Operating profit before amortisation, impairment, share based payments and non-recurring items

8,218

7,131

16,865

Amortisation of publishing rights, titles and benefits

(2,805)

(2,803)

(6,105)

Impairment of goodwill

-

-

(4,500)

Share-based payments

(429)

(354)

(888)

Non-recurring items

7

(200)

2,276

2,000

Operating profit

4,784

6,250

7,372

Finance income

8

2

1

4

Finance costs

8

(1,118)

(1,159)

(2,260)

Profit before tax

3,668

5,092

5,116

Taxation

9

(992)

(258)

(1,484)

Profit for the period

2,676

4,834

3,632

Attributable to :

Owners of the parent

2,618

4,789

3,537

Non-controlling interests

58

45

95

2,676

4,834

3,632

Earnings per share attributable to owners of the parent

Basic earnings per share

11

3.07p

5.67p

4.17p

Diluted earnings per share

11

2.98p

5.49p

4.07p

Adjusted basic earnings per share (''Adjusted Earnings Per Share'')

11

6.22p

5.47p

13.06p

Adjusted diluted earnings per share

11

6.04p

5.31p

12.74p

 

The above Consolidated Income Statement should be read in conjunction with the accompanying notes.

All items in the current and comparative periods relate to continuing activities.

 

Consolidated Statement of Comprehensive Income

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30June 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Profit for the period

2,676

 

4,834

3,632

Other comprehensive income/(expense)

 

Items that may be reclassified subsequently to the Income Statement

Interest rate swap fair value gain/(loss) taken directly to equity

319

(12)

286

Tax on interest rate swap gain/(loss) taken directly to equity

(67)

3

(80)

Exchange differences on translation of foreign operations

(89)

(51)

51

Fair value movements on net investment hedge

(135)

-

21

 

Other comprehensive income/(expense) for the period, net of tax

28

 

(60)

 

278

Total comprehensive income for the period

2,704

4,774

3,910

Total comprehensive income for the period attributable to :

- Owners of the parent

2,646

4,730

3,815

- Non-controlling interests

58

44

95

2,704

4,774

3,910

 

The above Consolidated Statement of Comprehensive Income should be read in conjunction with the accompanying notes.

 

 

 

Consolidated Balance Sheet

 

31 December 2013

31 December 2012

30 June

2013

(unaudited)

(unaudited)

(audited)

Note

£'000

£'000

£'000

Non-current assets

Goodwill

13

76,966

74,505

73,282

Intangible assets

13

32,042

28,886

31,493

Property, plant and equipment

13

5,743

6,430

5,909

Deferred tax asset

591

727

887

115,342

 

110,548

 

111,571

Current assets

Inventories

31

42

54

Trade and other receivables

14

22,096

18,849

21,325

Derivative financial assets

18

149

38

-

Cash and cash equivalents

8,077

4,000

7,803

30,353

 

22,929

 

29,182

Non-current assets held for sale

-

 

-

657

Total assets

145,695

 

133,477

141,410

Current liabilities

Trade and other payables

15

(37,707)

(32,181)

(39,254)

Current tax liabilities

(1,144)

(952)

(1,533)

Deferred consideration

(330)

(160)

(224)

Derivative financial liabilities

18

-

-

(63)

Bank overdrafts

(298)

-

(890)

Provision for the future purchase of non-controlling interests

16

(46)

-

-

(39,525)

 

(33,293)

(41,964)

Non-current liabilities

Bank loans

17

(47,705)

(37,341)

(39,751)

Deferred consideration - equity-settled

(619)

(648)

(619)

Deferred consideration - cash-settled

-

-

(261)

Derivative financial liabilities

18

(777)

(1,458)

(1,096)

Deferred tax liability

(5,184)

(5,755)

(5,822)

Provision for the future purchase of non-controlling interests

16

(146)

(171)

(183)

(54,431)

 

(45,373)

 

(47,732)

Total liabilities

(93,956)

 

(78,666)

 

(89,696)

Net assets

51,739

 

54,811

 

51,714

Equity

Share capital

19

4,305

4,305

4,305

Share premium

19

45,231

45,231

45,231

Treasury shares

19

(878)

(2,356)

(2,356)

Translation reserve

(30)

43

59

Share based payments reserve

696

1,126

1,560

Retained earnings

2,238

6,352

2,770

Equity attributable to owners of the parent

51,562

 

54,701

51,569

Non-controlling interests

177

110

145

Total equity

51,739

54,811

51,714

 

The above Consolidated Balance Sheet should be read in conjunction with the accompanying notes.

Consolidated Statement of Changes in Equity

 

 

 Attributable to Equity Shareholders of the Company

 

Share capital (note 19)

£'000

Share based payment reserve

£'000

 

 

Translation reserve

£'000

 

 

Retained earnings

£'000

Total

£'000

Non- controlling interests

£'000

Total equity

£'000

At 1 July 2012 (audited)

45,528

815

93

5,160

51,596

-

51,596

Profit for the period

-

-

-

4,789

4,789

45

4,834

Exchange differences on translation of foreign operations

-

-

(50)

-

(50)

(1)

(51)

Fair value movements on interest rate swaps

-

-

-

(12)

(12)

-

(12)

Tax on other comprehensive income

-

-

-

3

3

-

3

45,528

815

43

9,940

56,326

44

56,370

Dividends to shareholders

-

-

-

(2,974)

(2,974)

(27)

(3,001)

Share-based payments

-

311

-

-

311

-

311

Reissue of treasury shares

1,652

-

-

(614)

1,038

-

1,038

Movements in non-controlling interests

-

-

-

-

-

80

80

Movements in offset of provision for the future purchase of non-controlling interests

-

-

-

-

-

13

13

At 31 December 2012 (unaudited)

47,180

1,126

43

6,352

54,701

110

54,811

Loss for the period

-

-

-

(1,252)

(1,252)

50

(1,202)

Exchange differences on translation of foreign operations

-

-

101

-

101

1

102

Fair value movements on interest rate swaps

-

-

-

298

298

-

298

Fair value movements on net investment hedge

-

-

-

21

21

-

21

Tax on other comprehensive income

-

-

-

(83)

(83)

-

(83)

47,180

1,126

144

5,336

53,786

161

53,947

Dividends to shareholders

-

-

-

(2,973)

(2,973)

-

(2,973)

Share-based payments

-

434

-

322

756

-

756

Translation reserve realised on disposal of overseas subsidiary

-

-

(85)

85

-

-

-

Movements in offset of provision for the future purchase of non-controlling interests

-

-

-

-

-

(16)

(16)

At 30 June 2013 (audited)

47,180

1,560

59

2,770

51,569

145

51,714

Profit for the period

-

-

-

2,618

2,618

58

2,676

Exchange differences on translation of foreign operations

-

-

(89)

-

(89)

-

(89)

Fair value movements on interest rate swaps

-

-

-

319

319

-

319

Fair value movements on net investment hedges

-

-

-

(135)

(135)

-

(135)

Tax on other comprehensive income

-

-

-

(67)

(67)

-

(67)

47,180

1,560

(30)

5,505

54,215

203

54,418

Dividends to shareholders

-

-

-

(2,974)

(2,974)

(26)

(3,000)

Share-based payments

-

225

-

41

266

-

266

Reissue of treasury shares

1,478

(1,089)

-

(334)

55

-

55

Movements in non-controlling interests

-

-

-

-

-

-

-

Movements in offset of provision for the future purchase of non-controlling interests

-

-

-

-

-

-

-

At 31 December 2013 (unaudited)

48,658

696

(30)

2,238

51,562

177

51,739

 

The above Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes.

Consolidated Cash Flow Statement

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30June 2013

(unaudited)

(unaudited)

(audited)

Note

£'000

£'000

£'000

Cash flows from operating activities

Cash generated from operations before non-recurring items

20

5,833

5,159

19,411

Net finance costs paid

(859)

(984)

(2,011)

Tax paid

(1,690)

(1,280)

(2,926)

Net cash inflow from operating activities

3,284

2,895

14,474

Cash flows from investing activities

Purchase of businesses

(7,342)

-

(1,151)

Deferred consideration paid

(168)

(161)

(171)

Purchase of subsidiaries

-

-

(5,523)

Purchase of non-controlling interests

16

-

(1,707)

(1,707)

Cash acquired on purchase of subsidiaries

-

-

547

Cash received from non-controlling interests

-

80

80

Non-recurring costs

(200)

(633)

(1,224)

Purchase of property, plant and equipment

13

(407)

(506)

(1,217)

Proceeds from disposal of property, plant and equipment

710

4,407

4,450

Purchase of intangible assets

13

(228)

(261)

(764)

 

Net cash (outflow)/inflow from investing activities

(7,635)

 

1,219

 

(6,680)

Cash flows from financing activities

Dividends paid to owners of the parent

(2,974)

(2,974)

(5,947)

Dividends paid to non-controlling interests

(26)

(27)

(27)

Reissue of treasury shares

55

1,038

1,038

Increase in long-term loans

8,562

-

2,286

Net cash inflow/(outflow) from financing activities

5,617

 

(1,963)

 

(2,650)

Net increase in cash and cash equivalents, net of bank overdrafts

1,266

2,151

5,144

Cash and cash equivalents, net of bank overdrafts, at beginning of the period

6,913

 

1,795

 

1,795

Cash and cash equivalents, net of bank overdrafts, at end of the period

8,179

3,946

6,939

Reconciliation of net debt

Cash and cash equivalents at beginning of the period

7,803

3,954

3,954

Bank overdrafts at beginning of the period

(890)

(2,159)

(2,159)

Bank loans at beginning of the period

17

(40,286)

(38,000)

(38,000)

Net debt at beginning of the period

(33,373)

(36,205)

(36,205)

Net increase in cash and cash equivalents, net of bank overdrafts

1,266

2,151

5,144

(Increase) in long-term loans

(8,562)

-

(2,286)

Effect of foreign exchange rate changes

331

54

(26)

Cash and cash equivalents at end of the period

8,077

4,000

7,803

Bank overdrafts at end of the period

(298)

-

(890)

Bank loans at end of the period

17

(48,117)

(38,000)

(40,286)

Net debt at end of the period

(40,338)

(34,000)

(33,373)

 

The above Cash Flow Statement should be read in conjunction with the accompanying notes.

Notes to the Financial Results

 

1. General information

 

The Company is a public limited company incorporated and domiciled in the UK. The address of its registered office is 6-14 Underwood Street, London N1 7JQ.

 

The Company has its primary listing on the London Stock Exchange.

 

This condensed consolidated interim financial information (''Interim Information'') was approved for issue on 25 February 2014.

 

The Interim Information is unaudited and does not comprise statutory accounts within the meaning of section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 June 2013 were approved by the Board of Directors on 18 September 2013. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under section 498 of the Companies Act 2006.

 

2. Basis of preparation

 

This Interim Information for the six months ended 31 December 2013 has been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority and in accordance with IAS 34 ''Interim financial reporting'' as adopted by the European Union. The Interim information should be read in conjunction with the Annual Financial Statements for the year ended 30 June 2013 which have been prepared in accordance with IFRSs as adopted by the European Union, and are available on the Group's website www.wilmington.co.uk.

 

Going Concern

The Group's forecast and projections, taking account of reasonably possible changes in trading performance, show that the Group will be able to operate well within the level of its current banking facilities. The Directors have therefore adopted a going concern basis in preparing the Interim Information.

 

3. Accounting policies

 

The accounting policies applied are consistent with those of the Annual Financial Statements for the year ended 30 June 2013, as described in those Annual Financial Statements.

 

The following new standards and amendments to standards are mandatory for the first time for the financial year beginning 1 July 2013 but are either not relevant to the Group or do not have a significant impact: 

 

· IFRS 10 "Consolidated Financial Statements'':

IFRS 10 builds on existing principles by identifying the concept of control as the determining factor in whether an entity should be included within the consolidated financial statements.

· IFRS 11 "Joint arrangements'':

IFRS 11 provides for a more realistic reflection of joint arrangements by focusing on the rights and obligations of the arrangement, rather than its legal form. The Group has no such arrangements.

· IFRS 12 "Disclosure of interests in other entities'':

IFRS 12 includes the disclosure requirements for all forms of interests in other entities, including joint arrangements, associates, special purpose vehicles and other off-balance-sheet vehicles. The Group has no interests in such other entities.

· IFRS 13 "Fair value measurement'':

IFRS 13 seeks to increase consistency and comparability in fair value measurements and related disclosures. It defines fair value, sets out a framework for measuring fair value, and requires disclosures about fair value measurements. It applies when another IFRS requires or permits fair value measurements or disclosures about fair value measurements. The fair value disclosures in the Annual Financial Statements will be reassessed in the context of IFRS 13, but this new standard is not anticipated to have a significant impact on the Group.

· ''Annual Improvements to IFRSs 2009-2011 Cycle'':

Amendments include an amendment to IAS 1 "Presentation of Financial Statements'' to clarify the requirements for providing comparative information, and an amendment to IAS 32 "Financial Instruments: Presentation'' to clarify the income tax consequences of distributions to holders of an equity instrument. The amendments are not anticipated to have a significant impact on the Group.

· IAS 19 "Employee benefits'':

These amendments eliminate the corridor approach and calculate finance costs on a net funding basis. The

 Group does not operate a defined benefit pension scheme.

· IAS 27 "Separate Financial Statements'':

This standard includes the provisions on separate financial statements that are left after the control provisions of IAS 27 have been included in the new IFRS 10.

· IAS 28 "Investments in associates and joint ventures'':

 

This standard includes the requirements for joint ventures, as well as associates, to be equity accounted following the issue of IFRS 11. The Group has no investments in associates and joint ventures.

· Amendment to IFRS 1 "First time adoption on government loans'':

This amendment addresses how a first-time adopter would account for a government loan with a below-market rate of interest when transitioning to IFRS. It also adds an exception to the retrospective application of IFRS, which provides the same relief to first-time adopters granted to existing preparers of IFRS financial statements when the requirement was incorporated into IAS 20 in 2008. The Group receives no government loans.

· Amendment to IFRS 7 "Financial instruments asset and liability offsetting'':

This amendment reflects the joint IASB and FASB requirements to enhance current offsetting disclosures. These new disclosures are intended to facilitate comparison between those entities that prepare IFRS financial statements and those that prepare US GAAP financial statements. The Group reports under IFRS only.

 

The following new standards and amendments to standards have been issued but are not yet effective for the purposes of the Interim Report and have not been early adopted:

 

· IFRS 9 "Financial instruments'' - effective date: periods beginning on or after 1 January 2015.

· Amendments to IFRS 9 ''Financial instruments, regarding general hedge accounting'' - effective date: not yet specified.

· IFRS10 "Consolidated financial statements', IFRS 12 and IAS 27 for investment entities'' - effective date: periods beginning on or after 1 January 2014.

· Amendments to IAS 19 "Defined benefit plans'' - effective date: periods beginning on or after 1 July 2014.

· Amendments to IAS 32 "Financial Instruments: Presentation'' on offsetting financial assets and financial liabilities - effective date: periods beginning on or after 1 January 2014.

· Amendments to IAS 36 "Impairment of assets'' - effective date: periods beginning on or after 1 January 2014.

· Amendments to IAS 39 "Financial Instruments: Recognition and measurement'' on novation of derivatives and hedge accounting - effective date: periods beginning on or after 1 January 2014.

 

4. Principal risks and uncertainties

 

The principal business risks that affect the Group are as stated on pages 20 and 21 of the Business Review in the Annual Report and Financial Statements for the year ended 30 June 2013.

 

The main financial risks that affect the Group are:

 

(a) Liquidity and capital risk

The Group has an unsecured committed bank facility of £65m (2012: £65m) to February 2016. The facility currently comprises a revolving credit facility of £60m (2012: £60m) and an overdraft facility of £5m (2012: £5m). At 31 December 2013, £48m (2012: £38m) of the revolving credit facility was drawn down. The bank overdrafts are the subject of a Group set-off arrangement.

 

The Group met the requirements of the bank facility financial covenants throughout the period.

 

(b) Interest rate risk

The Group financing arrangements include external debt that is subject to a variable interest rate. The Group is consequently exposed to cash flow volatility arising from fluctuations in market interest rates applicable to that external finance. In particular, interest is charged on the £48m (2012: £38m) amountdrawn down on the revolving credit facility at a rate of between 2.00 and 2.75 per cent above LIBOR depending upon leverage. Cash flow volatility therefore arises from movements in the LIBOR interest rates.

 

The Group finances its operations through a mixture of retained profits, operational cash flow and bank borrowings. Historically the Group has expanded its operations both organically and by acquisition, which has led on occasions to the need for external finance.

 

 In November 2010, the Group entered into two hedging instruments. Firstly, a 5 year £15m interest rate swap fixed against 3 month LIBOR with a forward start of 21 November 2011 paying interest on £15m at a fixed rate of 2.68% was entered into. Secondly, in November 2010, a 3 year £10m interest rate swap fixed against 3 month LIBOR with a forward start of 21 November 2011 paying interest on £10m at a fixed rate of 2.12% was entered into. These derivatives have been designated as a cash flow hedges in order to manage interest rate risk associated with the first £25m of the credit facility. Payments received under the swaps have been matched against interest paid quarterly during the period and the entire mark to market loss on the derivatives have been recognised in equity, following the Directors' assessment of the hedge's effectiveness.

 

The fair value of the interest rate swap derivatives at 31 December 2013 was £0.8m (2012: £1.5m).

 

(c) Foreign currency risk

The Group has significant Euro and US dollar cash flows arising from international trading and overseas operations. The Group is consequently exposed to cash flow volatility arising from fluctuations in the applicable exchange rates for converting Euros and US dollars to Sterling.

 

The Group policy is to fix the exchange rate in relation to a periodically reassessed set percentage of expected Euro and US dollar net cash inflows arising from international trading by entering into foreign currency contracts to sell a specified amount of Euros or US dollars on a specified future date at a specified exchange rate. Details of the forward currency contracts in the financial year are as follows:

· On 22 April 2013, the Group sold forward $1.0m to 10 December 2013 at a rate of 1.5248. On 20 June 2013, the Group sold forward $2.0m to 31 October 2013 at a rate of 1.545, $1.0m to 28 February 2014 at a rate of 1.5419, and $2.5m to 31 March 2014 at a rate of 1.5417. These contracts were entered into in order to provide certainty in Sterling terms of 80% of the Group's net US dollar income.

· On 28 June 2013, the Group sold forward €0.5m to 30 September 2013 at a rate of 1.1673, €1.5m to 30 September 2013 at a rate of 1.1673, €1.0m to 29 November 2013 at a rate of 1.1664, and €0.5m to 28 February 2014 at a rate of 1.1655. These contracts were entered into in order to provide certainty in Sterling terms of 80% of the Group's net Euro income.

 

The Group policy is to finance investment in overseas operations from borrowings in the local currency of the relevant operation, so as to achieve a natural hedge of the foreign currency translation risk.

 

In March 2013, the Group purchased the business and assets of Inese, an operation in Spain. This was financed using a €1.5m drawdown on the Group's multi-currency revolving loan facility.

 

The Group also purchased, on 15 August 2013, the business and assets of Compliance Week, an operation in America. The Group financed this acquisition via a $12m drawdown on the Group's multi-currency revolving loan facility.

 

These debts have been designated as a currency hedge of a net investment in a foreign operation for accounting purposes and are translated into sterling at each reporting date giving rise to a gain or loss, the entire amount of which is recognised in equity following the Directors' assessment of the hedge's effectiveness.

 

5. Adjusted Profit

 

To provide shareholders with a better understanding of the trading performance of the Group, Adjusted Profit has been calculated as profit before tax after adding back:

 

· amortisation of publishing rights, titles and benefits;

· impairment of goodwill;

· unwinding of the discount on deferred consideration;

· unwinding of the discount on the provision for the future purchase of non-controlling interests;

· share-based payments; and

· non-recurring items (including net gain on disposal of property).

 

Adjusted Profit reconciles to profit before tax as follows:

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30June 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Profit before tax

3,668

5,092

5,116

Net finance costs (excluding the unwinding of the discounts)

1,094

1,110

2,163

Unwinding of the discount on the provision for the future purchase of non-controlling interests (see note 16)

9

 

6

16

Unwinding of the discount on deferred consideration

13

42

77

Operating profit

4,784

6,250

7,372

Amortisation of publishing rights, titles and benefits (see note 13)

2,805

 

2,803

 

6,105

Impairment of goodwill (see note 13)

-

-

4,500

Share-based payments

429

354

888

Net gain on disposal of property (see note 7)

-

(3,319)

(3,325)

Other non-recurring items (see note 7)

200

1,043

1,325

Operating profit before amortisation, impairment, share based payments and non-recurring items (''Adjusted EBITA'')

8,218

 

7,131

16,865

Depreciation of property, plant and equipment (see note 13)

484

515

1,043

Amortisation of computer software (see note 13)

433

317

755

Adjusted EBITA before depreciation (''Adjusted EBITDA'')

9,135

7,963

18,663

 

 

Adjusted Profit before Tax is calculated as follows:

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30

June 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Adjusted EBITA (as above)

8,218

 

7,131

16,865

Net finance costs (excluding the unwinding of the discounts)

(1,094)

(1,110)

(2,163)

Adjusted Profit before Tax

7,124

6,021

14,702

 

6. Segmental information

 

The Group's operating segments are reported in a manner consistent with the internal financial information provided to the Board, which represents the chief operating decision maker.

 

The Group's organisational structure reflects the different professional markets to which it provides information, compliance and education. The six professional divisions (Pensions & Insurance, Banking & Compliance, Healthcare, Legal, Business Intelligence and Accountancy) are the Group's reportable segments and generate all of the Group's revenue.

 

The Board considers the business from both a geographic and product perspective. Geographically, management considers the performance of the Group between the UK and overseas.

 

(a) Business segments

 

Six months ended 31 December 2013 (unaudited)

Revenue

Contribution

£'000

£'000

Pensions & Insurance

8,284

3,506

Banking & Compliance

10,728

2,692

Healthcare

6,770

1,551

Legal

8,398

577

Business Intelligence

4,268

767

Accountancy

4,699

680

Unallocated central overheads

-

(1,555)

Total revenue

43,147

Operating profit before amortisation, impairment, share based payments and non-recurring items (''Adjusted EBITA'')

8,218

Amortisation of publishing rights, titles and benefits (see note 13)

(2,805)

Net gain on disposal of property (see note 7)

-

Other non-recurring items (see note 7)

(200)

Share-based payments

(429)

Net finance costs

(1,094)

Unwinding of discounts

(22)

Profit for the period before tax

3,668

Taxation (see note 9)

(992)

Profit for the period

2,676

 

 

Six months ended 31 December 2012 (unaudited)

Revenue

Contribution

£'000

£'000

Pensions & Insurance

6,534

2,886

Banking & Compliance

8,749

2,071

Healthcare

6,009

1,294

Legal

9,510

657

Business Intelligence

5,271

998

Accountancy

4,851

727

Unallocated central overheads

-

(1,502)

Total revenue

40,924

Operating profit before amortisation, impairment, share based payments and non-recurring items (''Adjusted EBITA'')

7,131

Amortisation of publishing rights, titles and benefits (see note 13)

(2,803)

Net gain on disposal of property (see note 7)

3,319

Other non-recurring items (see note 7)

(1,043)

Share-based payments

(354)

Net finance costs

(1,110)

Unwinding of discounts

(48)

Profit for the period before tax

5,092

Taxation (see note 9)

(258)

Profit for the period

4,834

 

Twelve months ended 30 June 2013 (audited)

Revenue

Contribution

£'000

£'000

Pensions & Insurance

14,629

6,093

Banking & Compliance

16,566

3,513

Healthcare

13,058

2,836

Legal

19,266

2,884

Business Intelligence

10,948

2,523

Accountancy

10,581

2,135

Unallocated central overheads

-

(3,119)

Total revenue

85,048

Operating profit before amortisation, impairment, share based payments and non-recurring items (''Adjusted EBITA'')

16,865

Amortisation of publishing rights, titles and benefits (note 13)

(6,105)

Impairment of goodwill (see note 13)

(4,500)

Net gain on disposal of property (see note 7)

3,325

Other non-recurring items (see note 7)

(1,325)

Share-based payments

(888)

Net finance costs

(2,163)

Unwinding of discounts

(93)

Profit for the period before tax

5,116

Taxation (see note 9)

(1,484)

Profit for the period

3,632

 

 

(b) Segmental information by geography

 

The UK is the Group's country of domicile and the Group generates the majority of its revenue from external customers in the UK. The geographical analysis of revenue is on the basis of the country of origin in which the customer is invoiced:

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30June 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

UK

27,983

28,918

58,159

Europe, excluding the UK

7,057

5,373

13,070

North America

5,058

3,982

7,422

Rest of the World

3,049

2,651

6,397

43,147

40,924

85,048

 

7. Non-recurring items

 

The following items have been charged/(credited) to profit or loss during the year but are of an unusual nature, size or incidence and so are shown as non-recurring items:

 

Six months ended 31 December 2013

(unaudited)

£'000

Six months ended 31 December 2012

(unaudited)

£'000

Twelve months ended 30

 June 2013

(audited)

£'000

Net gain on disposal of property

-

3,319

3,325

Costs written off relating to both successful and abortive acquisitions

(200)

(16)

(270)

Restructuring and rationalisation costs

-

(397)

(593)

Impairment of property, plant and equipment (note 13)

-

(325)

(325)

Costs relating to rationalisation of publishing operations

-

(305)

(339)

Reduction in liability for deferred consideration

-

-

440

Termination costs of joint venture contract

-

-

(238)

Total other non-recurring items

(200)

(1,043)

(1,325)

Total non-recurring items

(200)

2,276

2,000

 

8. Finance income and costs

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30

June 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Finance income comprises:

Bank interest receivable

2

1

4

Finance costs comprise:

Interest payable on bank loans and overdrafts

(872)

(849)

(1,653)

Facility fees

(100)

(138)

(267)

Write off of loan arrangement fee

(124)

(124)

(247)

Unwinding of the discount on the provision for the future purchase of non-controlling interests (see note 16)

(9)

(6)

(16)

Unwinding of the discount on deferred consideration

(13)

(42)

(77)

(1,118)

(1,159)

(2,260)

 

 

9. Taxation

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30

 June 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Current tax:

UK corporation tax at current rates on profits for the period

632

769

2,382

Adjustments in respect of previous years

(28)

(20)

30

604

749

2,412

Foreign tax

705

359

854

Adjustments to foreign tax in respect of previous years

(9)

2

(4)

Total current tax

1,300

1,110

3,262

 

Deferred tax:

Deferred tax credit

(52)

(730)

(1,469)

Adjustments to deferred tax in respect of previous years

4

-

(41)

Effect on deferred tax of change in corporation tax rate

(260)

(122)

(268)

Total deferred tax

(308)

(852)

(1,778)

Taxation

992

258

1,484

 

10. Dividends

 

Distributions to owners of the parent in the period:

 

Six

months ended 31 December 2013

Six

months ended 31 December 2012

Twelve months ended 30 June

2013

Six

months ended 31 December 2013

Six

months ended 31 December 2012

Twelve months ended 30 June

2013

pence per share

pence per share

pence per share

£'000

£'000

£'000

(unaudited)

(unaudited)

(audited)

(unaudited)

(unaudited)

(audited)

Final dividends recognised as distributions in the year

3.50

3.50

3.50

2,974

2,974

2,973

Interim dividends recognised as distributions in the year

-

-

3.50

-

-

2,974

Total dividends paid in the period

2,974

2,974

5,947

Interim dividend proposed

3.60

3.50

3.50

3,084

2,974

2,974

 

11. Earnings per share

 

Adjusted Earnings per Share has been calculated using adjusted earnings calculated as profit after tax and non-controlling interests but before:

 

· amortisation of publishing rights, titles and benefits;

· impairment of goodwill;

· unwinding of the discount on deferred consideration;

· unwinding of the discount on the provision for the future purchase of non-controlling interests;

· share-based payments; and

· non-recurring items (including net gain on disposal of property).

 

 

The calculation of the basic and diluted earnings per share is based on the following data:

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30June2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Earnings from continuing operations for the purpose of basic earnings per share

2,618

4,789

3,537

Add/(remove):

Amortisation of publishing rights, titles and benefits (net of non-controlling interest effect)

2,805

2,803

6,105

Impairment of goodwill

-

-

4,500

Net gain on disposal of property

-

(3,319)

(3,325)

Other non-recurring items

200

1,043

1,325

Share based payments

429

354

888

Unwinding of the discount on the provision for the future purchase of non-controlling interests

9

 

6

16

Unwinding of the discount on deferred consideration

13

42

77

Tax effect

(773)

(1,092)

(2,057)

Adjusted earnings for the purposes of adjusted earnings per share

5,301

4,626

11,066

Number

Number

Number

Weighted average number of ordinary shares for the purpose of basic and adjusted earnings per share

85,251,725

84,494,470

84,727,804

Effect of dilutive potential ordinary shares:

Future exercise of share options

2,292,566

2,683,458

1,992,729

Deferred consideration to be settled by equity

257,648

-

156,550

Weighted average number of ordinary shares for the purposes of diluted earnings per share

87,801,939

87,177,928

86,877,083

Basic earnings per share

3.07p

5.67p

4.17p

Diluted earnings per share

2.98p

5.49p

4.07p

Adjusted basic earnings per share (''Adjusted Earnings Per Share'')

6.22p

5.47p

13.06p

Adjusted diluted earnings per share

6.04p

5.31p

12.74p

 

12. Business combinations

 

The Group acquired the trading assets and certain liabilities of Compliance Week ("Compliance Week"), the leading provider of governance, risk and compliance ("GRC") information and events for public companies and large enterprises primarily in the US on 15 August 2013. Compliance Week was acquired for a net consideration of $11.215m (£7.411m) in cash. Subsequently, $0.196m (£0.129m) was repaid to the Group in respect of the net current asset adjustment. Further contingent consideration of up to $3m is potentially payable in cash subject to Compliance Week achieving challenging profit growth targets in the financial year ended 30 June 2015.

 

IFRS 3 (revised) was applied to the acquisition of Compliance Week. At present, the fair valuation of the assets and liabilities acquired has not been completed and the values below for intangible assets and goodwill are provisional. The final results of this fair valuation exercise will be reflected in the Financial Statements for the year ended 30 June 2014. An estimate of any contingent consideration due will also be included in the Financial Statements for the year ended 30 June 2014 and would result in a corresponding increase in the value of goodwill.

 

Acquisition-related costs of £173,000 have been recognised as part of the costs written off relating to both successful and abortive acquisitions of £200,000 shown as non-recurring items in the Income Statement (see note 7).

 

The acquisition of Compliance Week is consistent with the Group's strategy of acquiring businesses with high repeat revenues and strong, cash generative income streams in the Group's key markets. The Business forms part of Banking & Compliance Division and works closely with other Group companies, providing them with closer access to their North American customers and markets as well as opportunities for developing new revenue streams.

 

Details of the purchase consideration, the net assets acquired and goodwill are as follows:

 

£'000

Purchase consideration

Initial cash paid

7,411

Net current asset adjustment repayment

(129)

Net purchase consideration paid

7,282

The provisional fair value assets and liabilities recognised as a result of the acquisition are as follows:

 

Provisional fair value

£'000

Total intangible assets (see note 13)

3,965

Trade and other receivables

558

Subscriptions and deferred revenue

(1,075)

Trade and other payables

(131)

Net identifiable assets acquired

3,317

Provisional goodwill (see note 13)

3,965

7,282

The goodwill is attributable to Compliance Week's strong position and profitability in trading in the international compliance and regulatory information market, the new product development potential and synergies expected to arise after the Company's acquisition of the new subsidiary.

 

The acquired businesses contributed revenues of £1,173,000 and profit before divisional overheads, tax and amortisation, of £214,000 to the Group for the period from their date of acquisition to 31 December 2013. If the acquisitions had occurred on 1 July 2013, consolidated revenue and consolidated operating profit before amortisation, impairment, share based payments and non-recurring items for the six months ended 31 December 2013 would have been £43,509,000 and £8,267,000 respectively.

 

A further £60,000 was incurred as a net asset adjustment relating to NHiS Limited, a company acquired in February 2013. Further details of this acquisition are disclosed in note 12 of the Financial Statements for the year ended 30 June 2013.

 

 

13. Goodwill, Intangible assets and Property, plant and equipment

 

Goodwill

£'000

Intangible assets

£'000

Property, plant and equipment

£'000

At 1 July 2012 (audited)

74,593

31,522

6,772

Additions

-

261

506

Acquisitions

-

245

-

Disposals

-

(22)

(12)

Exchange translation differences

-

-

4

Depreciation of property, plant and equipment

-

-

(515)

Amortisation of publishing rights, titles and benefits

-

(2,803)

-

Amortisation of computer software

-

(317)

-

Impairment of property, plant and equipment

-

-

(325)

Change in provision for the future purchase of non-controlling interests

 

(101)

 

-

-

Movement in offset of provision for the future purchase of non-controlling interests

 

13

 

-

-

Closing net book amount as at 31 December 2012 (unaudited)

 

74,505

 

28,886

6,430

Additions

-

503

711

Acquisitions

3,291

5,801

35

Sale of subsidiary undertakings

-

(2)

Disposals

-

22

(80)

Transfer to assets held for sale

-

-

(658)

Exchange translation differences

-

21

1

Depreciation of property, plant and equipment

-

-

(528)

Amortisation of publishing rights, titles and benefits

-

(3,302)

-

Amortisation of computer software

-

(438)

-

Impairment of goodwill

(4,500)

-

-

Change in provision for the future purchase of non-controlling interests

2

-

-

Movement in offset of provision for the future purchase of non-controlling interests

(16)

-

-

Closing net book amount as at 30 June 2013 (audited)

73,282

31,493

5,909

Additions

60

228

407

Acquisitions

3,965

3,965

-

Disposals

-

(48)

(21)

Transfer to assets held for sale

-

-

-

Exchange translation differences

(341)

(358)

(68)

Depreciation of property, plant and equipment

-

-

(484)

Amortisation of publishing rights, titles and benefits

-

(2,805)

-

Amortisation of computer software

-

(433)

-

Closing net book amount as at 31 December 2013 (unaudited)

76,966

32,042

5,743

 

14. Trade and other receivables

 

31 December 2013

(unaudited)

£'000

31 December 2012

(unaudited)

£'000

30 June

2013

(audited)

£'000

Trade receivables

18,244

14,887

17,211

Other receivables

1,585

1,210

1,968

Prepayments and accrued income

2,267

2,752

2,146

22,096

18,849

21,325

 

 

 

15. Trade and other payables

 

31 December 2013

(unaudited)

£'000

31 December 2012

(unaudited)

£'000

30 June

2013

(audited)

£'000

Trade payables

4,092

2,077

3,995

Other payables

2,775

3,383

2,623

Social security and other taxes

2,676

2,781

3,591

Subscriptions and deferred revenue

19,227

15,594

18,563

Accruals

8,937

8,346

10,482

37,707

32,181

39,254

 

16. Provision for the future purchase of non-controlling interests

 

Current provision

£'000

Non-current provision

£'000

At 1 July 2012 (audited)

1,808

165

Amounts paid in respect of acquisitions of non-controlling interests

(1,707)

-

Unwinding of discount

-

6

Change in value of existing provision

(101)

-

 

At 31 December 2012 (unaudited)

-

171

Unwinding of discount

-

10

Change in value of existing provision

-

2

 

At 30 June 2013 (audited)

-

183

Amounts paid in respect of acquisitions of non-controlling interests

-

-

Unwinding of discount

-

9

Change in value of existing provision

-

-

Non-current provision becoming current

46

(46)

At 31 December 2013 (unaudited)

46

146

 

The provision represents the estimated future cost (discounted to reflect the time value of money) required to settle put options held by non-controlling shareholders over non-controlling interest shares, should the put options be exercised.

 

The actual settlement timing and value is dependent upon when (and if) the non-controlling shareholders choose to exercise their options and on the profitability of the underlying companies at the date of exercise. For the purposes of estimating the above provision, it has been assumed that put options are exercised at the first available opportunity.

 

17. Bank loans

 

31 December 2013

£'000

(unaudited)

31 December 2012

£'000

(unaudited)

30 June 2013

£'000

(audited)

 

Non-current liability

Bank loans

48,117

38,000

40,286

Facility fees

(412)

(659)

(535)

Bank loans net of facility fees

47,705

37,341

39,751

 

Details of the Group's bank facilities are set out in note 4(a).

 

18. Financial risk management and financial instruments.

 

The methods and assumptions used to estimate the fair values of financial assets and liabilities are as follows:

 

· The carrying amount of trade receivables and payables approximates to fair value due to the short maturity of the amounts receivable and payable.

 

· The fair value of the Group's borrowings is estimated on the basis of the discounted value of future cash flows using approximate discount rates in effect at the balance sheet date.

 

· The fair value of the Group's outstanding interest rate swaps, foreign exchange contracts and put options for non-controlling interest are estimated using discounted cash flow models and market rates of interest and foreign exchange at the balance sheet date.

 

The table below analyses financial instruments measured at fair value via a valuation method. The different levels have been defined as:

 

Level 1

Quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2

Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices); and

Level 3

Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs).

 

31 December 2013

(unaudited)

£'000

31 December 2012

(unaudited)

£'000

30 June

2013

(audited)

£'000

£'000

£'000

£'000

Assets

Financial assets at fair value through income or expense

-Trading derivatives at fair value through the Income Statement

149

38

-

Total assets

149

38

-

Liabilities

Financial liabilities at fair value through income or expense

-Trading derivatives at fair value through the Income Statement

-

-

(63)

Financial liabilities at fair value through equity

 

 

 

-Derivative financial instruments designated for hedging

(777)

(1,458)

(1,096)

Total liabilities

(777)

(1,458)

(1,159)

 

All financial instruments are level 2 financial instruments for all periods and there have been no transfers between either level 1 and level 2 or level 2 and 3 in any period.

 

19. Share capital

 

Number of ordinary shares

of 5p each

Ordinary shares

£'000

Share premium account

£'000

Treasury shares

£'000

Total

£'000

At 1 July 2012 (audited)

86,103,137

4,305

45,231

(4,008)

45,528

Treasury shares reissued during the period

-

 

-

 

-

 

1,652

 

1,652

At 31 December 2012 (unaudited) and 30 June 2013 (audited)

86,103,137

4,305

45,231

(2,356)

47,180

Treasury shares reissued during the period

-

-

-

1,478

1,478

At 31 December 2013 (unaudited)

86,103,137

4,305

45,231

(878)

48,658

 

During the period ended 31 December 2013, no ordinary shares (2012: nil) were issued.

 

The Company sold 668,910 treasury shares during the period ended 31 December 2013 (2012: nil) in respect of vesting of share awards to members of staff (including Directors).

 

The Company also sold 47,500 treasury shares during the period ended 31 December 2013 (2012: nil) in respect of share options exercised by members of staff.

 

 No other treasury shares were sold by the Company during the period ended 31 December 2013 (2012: 800,000).

 

At 31 December 2013, 425,590 shares (2012: 1,142,000) were held in Treasury, which represents 0.5% (2012: 1.3%) of the called up share capital of the Company.

 

20. Net cash flow from operating activities

 

Six months ended 31 December 2013

Six months ended 31 December 2012

Twelve months ended 30

June 2013

(unaudited)

(unaudited)

(audited)

Note

£'000

£'000

£'000

Profit before tax

3,668

5,092

5,116

Net gain on disposal of property

7

-

(3,319)

(3,325)

Other non-recurring items

7

200

1,043

1,325

Depreciation of property, plant and equipment

13

484

515

1,043

Impairment of goodwill

13

-

-

4,500

Amortisation of intangible assets

13

3,238

3,120

6,860

(Profit)/loss on disposal of property, plant and equipment

(32)

 

12

94

Loss on disposal of intangible assets

13

22

-

Share-based payments (including social security costs)

429

 

354

888

Net finance costs

8

1,116

1,158

2,256

Operating cash flows before movements in working capital

9,116

7,997

18,757

Cash paid relating to share based payments including social security costs

(358)

-

-

Decrease in inventories

23

17

5

(Increase)/decrease in receivables

(178)

1,016

59

(Decrease)/increase in payables

(2,770)

(3,871)

590

Cash generated by operations before non-recurring items

5,833

5,159

19,411

 

Cash conversion is calculated as a percentage of cash generated by operations to Adjusted EBITA as follows:

 

31 December 2013

(unaudited)

£'000

31 December 2012

(audited)

£'000

30 June 2013

(audited)

£'000

Adjusted EBITA (see note 5)

8218

7131

16,865

Funds from operations before non-recurring items

5,833

5,159

19,411

 

 

 

Cash conversion

71%

72%

115%

 

21. Related party transactions

 

The only related party transactions to have taken place during the period were normal business transactions between the Company and its subsidiary undertakings.

 

22. Seasonality

 

The Group has traditionally generated the majority of its revenues and profits during the second half of the financial year. This has historically resulted from three factors. Firstly, most of the Group's businesses (the notable exception being The Matchett Group) produce seasonally low sales in July, August and December which include holiday periods for many of the Group's clients. Secondly, Inese and Compliance Week, two of our recent acquisitions, have major annual events in the second half of the year. Thirdly, the publishing business produces a number of annual directory and database products, most of which are published in the second half of the financial year. To the extent that revenue is generated in the hard copy products this is recognised on publication. To the extent revenue relates to online content revenue is recognised over the period the content remains online. The migration over recent years of much of this revenue to the online products has resulted in a corresponding reduction in the seasonality of this revenue.

 

 

Statement of Directors' Responsibilities

 

The Directors confirm that, to the best of their knowledge, the Interim Information has been prepared in accordance with International Accounting Standard 34 Interim financial reporting as adopted by the European Union. The Interim Management Report includes a fair review of the Interim Information and, as required by DTR 4.2.7R and DTR 4.2.8R, the following information:

 

· an indication of important events that have occurred during the first six months of the financial year, and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

 

· disclosure of material related party transactions that have taken place in the first six months of the current financial year and of any material changes in the related party transactions described in the last Annual Report and Financial Statements.

 

The Directors of Wilmington Group plc are listed in the Wilmington Group plc Annual Report for 30 June 2013. A list of current Directors is maintained on the Wilmington Group plc website: www.wilmington.co.uk.

 

By order of the Board

 

Anthony Foye

Chief Finance Officer

25 February 2014

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR VZLFLZLFBBBL
Date   Source Headline
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company
20th Feb 20237:00 amRNSHalf-year Report
9th Feb 202312:36 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSNotice of Half Year-End Results
19th Dec 202211:32 amRNSHolding(s) in Company
12th Dec 20227:00 amRNSJoint Broker appointment
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:50 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
23rd Nov 20223:12 pmRNSResult of AGM
15th Nov 20222:31 pmRNSHolding(s) in Company
17th Oct 202212:11 pmRNSHoling(s) in Company
17th Oct 202212:11 pmRNSHolding(s) in Company
3rd Oct 20225:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20224:42 pmRNSSecond Price Monitoring Extn
30th Sep 20224:36 pmRNSPrice Monitoring Extension
29th Sep 20223:43 pmRNSHolding(s) in Company
29th Sep 20223:36 pmRNSIssue of ordinary shares
22nd Sep 20227:00 amRNSFinancial results for the year ended 30 June 2022
31st Aug 20227:00 amRNSNotice of Results
19th Aug 20225:07 pmRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSTotal Voting Rights
27th Jul 20227:00 amRNSYear-End Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.